Risperdal Class Action

risperdal class actionThe atypical antipsychotic medication, Risperdal, has been associated with gynecomastia (male breast development) and other serious side effects. Hundreds of plaintiffs are now pursuing Risperdal class action claims and other product liability lawsuits in order to obtain compensation for their alleged injuries.

Risperdal Gynecomastia Claims

Bernstein Liebhard LLP is currently representing a number of Risperdal plaintiffs who allegedly developed gynecomastia due to its use. If you or a loved one suffered similar side effects while taking this medication, please contact our Firm at (888) 994-5118 to learn more about your legal options.

The Risperdal Litigation

Risperdal is currently at the center of a massive litigation involving serious complications allegedly associated with its use. Plaintiffs have filed both class action and individual lawsuits in courts around the U.S. that claim Johnson & Johnson and Janssen Pharmaceuticals concealed its side effects and failed to warn the public about the drug’s risks. The companies are also accused of engaging in improper marketing by promoting Risperdal for a number of off-label indications.

One of the largest Risperdal litigations is currently underway in Pennsylvania’s Philadelphia Court of Common Pleas, where more than 1,600 product liability cases involving the drug have been centralized in a mass tort program. In 2015, the Court began trying lawsuits involving Risperdal and gynecomastia.

  • September 2012: The first male breast growth case slated to go before a jury in Pennsylvania is resolved via a confidential settlement. The accord is struck on the very day the trial was to begin.
  • October 2012: Additional agreements are reached to settle five more gynecomastia cases In Pennsylvania.
  • February 2015: Pennsylvania’s first Risperdal gynecomastia trial is convened, and involves a man who was prescribed the drug off-label as a child to treat symptoms associated with autism. The case concluded a month later with a $2.5 million judgment for the plaintiff. Read More
  • March 2015: A second Risperdal plaintiff is denied compensation, after the Pennsylvania jury hearing his case concludes that the drug was not responsible for his excessive breast growth. However, the panel does find that the gynecomastia warnings provided to patients and doctors were inadequate. Read More
  • May 2015: The case that should have been the third gynecomastia trial in Pennsylvania comes to an abrupt end, when the parties reach an undisclosed settlement. The agreement is announced just hours before opening arguments were to start. Read More
  • November 2015: The plaintiff in Pennsylvania’s third Risperdal trial is awarded $1.8 million. Testimony also continues in a forth gynecomastia trial that got underway in October. Read More

Should I Join a Risperdal Class Action Lawsuit?

If you’ve been hurt by Risperdal, you may be considering joining a class action lawsuit against Johnson & Johnson and Janssen Pharmaceuticals. These types of lawsuits allow one or more plaintiffs to file a claim on behalf of a larger group, or “class”, composed of other individuals who are also alleging similar injuries from the same product. The individual who files the lawsuit – the “lead” plaintiff” – is granted control over many important aspects of the case, including the choice of attorney, and whether or not to accept any proposed settlement on behalf of the class members.

When and if a class action case settles, attorneys fees are deducted, and the lead plaintiff is awarded an amount commiserate with their participation in the lawsuit. The remaining settlement is then divided among the remaining class members. Once the settlement has been approved by the Court, members have little recourse – other than opting out entirely – if they believe their award is unfair. If a case is unsuccessful, class members are usually barred from taking any further legal action.

The Risperdal attorneys at Bernstein Liebhard LLP believe that most plaintiffs will be best served by filing individual complaints. Doing so will allow you to choose your own attorney, and make all of the important decisions affecting its progress, including whether or not to go to trial or accept a settlement offer. In the case of Risperdal, victims have developed gynecomastia ranging from mild to very serious, and each plaintiff’s medical bills and other damages can be expected to vary greatly. For this reason, filing an individual lawsuit may provide the best chance of obtaining compensation appropriate to the damages you’ve incurred.

Learn More about Risperdal Lawsuits

If you’re considering filing a lawsuit against the manufacturers of Risperdal, you probably have many questions. The attorneys at Bernstein Liebhard LLP are available to discuss your case at no cost or obligation to you. Please call (888) 994-5118 to schedule a free legal consultation with our Firm.

  1. Bloomberg News (2012) “J&J Settles Risperdal Lawsuit on Opening Day of Trial” http://www.bloomberg.com/news/articles/2012-09-10/j-j-settles-risperdal-lawsuit-on-opening-day-of-trial
  2. Bloomberg News (2012) “Johnson & Johnson Agrees to Settle Five Risperdal Suits” http://www.bloomberg.com/news/articles/2012-10-04/johnson-johnson-agrees-to-settle-five-rispersal-suits
Last Modified: January 6, 2016

Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.

 
 
 

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest